Zosano Pharma Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Ladenburg Thalmann Downgrades Zosano Pharma (ZSAN) to Neutral
August 11, 2016 6:57 AM EDTLadenburg Thalmann downgraded Zosano Pharma (NASDAQ: ZSAN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Zosano Pharma click here. For more ratings news on Zosano Pharma click here.
Shares of Zosano Pharma closed at $1.39 yesterday.
... More